These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 15001192
1. Pulse wave analysis to assess vascular compliance changes in stable renal transplant recipients. Cohen DL, Warburton KM, Warren G, Bloom RD, Townsend RR. Am J Hypertens; 2004 Mar; 17(3):209-12. PubMed ID: 15001192 [Abstract] [Full Text] [Related]
2. Arterial elasticity measurement in renal transplant patients under anticalcineurin immunosuppression. Martínez-Castelao A, Sarrias X, Bestard O, Gil-Vernet S, Serón D, Cruzado JM, Moreso F, Díez-Noguera A, Grinyó JM. Transplant Proc; 2005 Nov; 37(9):3788-90. PubMed ID: 16386539 [Abstract] [Full Text] [Related]
3. The influence of calcineurin inhibitors on pulse wave velocity in renal transplant recipients. Strózecki P, Adamowicz A, Włodarczyk Z, Manitius J. Ren Fail; 2007 Nov; 29(6):679-84. PubMed ID: 17763162 [Abstract] [Full Text] [Related]
4. Associations between calcineurin inhibitors and arterial compliance in kidney transplant recipients. Wystrychowski G, Chudek J, Zukowska-Szczechowska E, Wiecek A, Grzeszczak W. J Nephrol; 2008 Nov; 21(1):81-92. PubMed ID: 18264940 [Abstract] [Full Text] [Related]
5. Increase in renal vascular resistance after intake of cyclosporin A and tacrolimus and reversal by nitroglycerin spray: a study in patients with stable renal allograft function. Weingart C, Leingärtner T, Bergler T, Krüger B, Böger C, Mack M, Banas B, Krämer BK. Int J Clin Pharmacol Ther; 2006 Sep; 44(9):422-7. PubMed ID: 16995330 [Abstract] [Full Text] [Related]
6. Differential effects of cyclosporine and tacrolimus on arterial function. Seibert F, Behrendt C, Schmidt S, van der Giet M, Zidek W, Westhoff TH. Transpl Int; 2011 Jul; 24(7):708-15. PubMed ID: 21569126 [Abstract] [Full Text] [Related]
7. Factors associated with increased arterial stiffness in renal transplant recipients. Strózecki P, Adamowicz A, Włodarczyk Z, Manitius J. Med Sci Monit; 2010 Jun; 16(6):CR301-6. PubMed ID: 20512094 [Abstract] [Full Text] [Related]
15. Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine. Jardine AG. Transpl Int; 2005 Apr; 18(4):379-84. PubMed ID: 15773954 [Abstract] [Full Text] [Related]
16. ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: a randomized clinical trial. Paoletti E, Cassottana P, Amidone M, Gherzi M, Rolla D, Cannella G. Am J Kidney Dis; 2007 Jul; 50(1):133-42. PubMed ID: 17591533 [Abstract] [Full Text] [Related]
17. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level. Calvo-Turrubiartes M, Romano-Moreno S, García-Hernández M, Chevaile-Ramos JA, Layseca-Espinosa E, González-Amaro R, Portales-Pérez D. Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271 [Abstract] [Full Text] [Related]